Merck & Company Inc (new)

MRK 
(NYSE) 
 
$ 84.94 <%= Resources.Global.txtDown %>
Updated 22/08/2019
Change % -2.05% Stock price decreasing
Change -1.78 Stock price decreasing
Volume 3,806,667
High $ 86.93
Low $ 84.48
Open $ 86.54
ISIN
Prev close $ 86.72
# of shares 2,560.37M
Market cap 217,478M USD
Intraday

Market closed
Merck & Company Inc (ne
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  84.94 -0.1% Stock price decreasing 3.9% Stock price increasing 4.6% Stock price increasing 5.7% Stock price increasing 23.0% Stock price increasing
Powered by TradingView

News about Merck & Company Inc (ne

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 81.93 -3.4% Stock price decreasing -6.9% Stock price decreasing 6.4% Stock price increasing 6.6% Stock price increasing 23.9% Stock price increasing 13.3% Stock price increasing
 
Baxter International Inc 85.03 -2.2% Stock price decreasing -0.2% Stock price decreasing 13.2% Stock price increasing 13.7% Stock price increasing 17.5% Stock price increasing 29.2% Stock price increasing
 
Bristol-Myers Squibb Company 46.58 -0.9% Stock price decreasing 2.6% Stock price increasing -0.5% Stock price decreasing -8.0% Stock price decreasing -22.3% Stock price decreasing -10.4% Stock price decreasing
 
Johnson & Johnson 127.73 -2.8% Stock price decreasing -2.6% Stock price decreasing -8.0% Stock price decreasing -6.2% Stock price decreasing -6.0% Stock price decreasing -1.0% Stock price decreasing
 
Eli Lilly and Company 109.51 -0.9% Stock price decreasing 1.6% Stock price increasing -6.2% Stock price decreasing -11.6% Stock price decreasing 3.5% Stock price increasing -5.4% Stock price decreasing
 
Pfizer Inc 34.34 -0.9% Stock price decreasing -19.5% Stock price decreasing -18.1% Stock price decreasing -20.3% Stock price decreasing -19.0% Stock price decreasing -21.3% Stock price decreasing
 
Gilead Sciences Inc 62.51 -1.0% Stock price decreasing -5.7% Stock price decreasing -6.5% Stock price decreasing -4.3% Stock price decreasing -15.1% Stock price decreasing -0.1% Stock price decreasing
 
Astrazeneca PLC ORD SHS $0.25 7,313.00 0.8% Stock price increasing 6.8% Stock price increasing 20.1% Stock price increasing 16.3% Stock price increasing 24.2% Stock price increasing 24.5% Stock price increasing
 
Merck Kgaa O.N. 94.90 0.6% Stock price increasing 0.9% Stock price increasing 4.7% Stock price increasing -0.4% Stock price decreasing 4.1% Stock price increasing 5.5% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,691.20 2.0% Stock price increasing 1.3% Stock price increasing 6.9% Stock price increasing 10.2% Stock price increasing 5.5% Stock price increasing 13.4% Stock price increasing
 
Sanofi 76.73 1.0% Stock price increasing 1.8% Stock price increasing 2.1% Stock price increasing 5.5% Stock price increasing 2.7% Stock price increasing 1.4% Stock price increasing
 
Novartis N 87.34 -0.2% Stock price decreasing -4.5% Stock price decreasing 0.1% Stock price increasing 8.3% Stock price increasing 20.1% Stock price increasing 17.6% Stock price increasing
 
Roche GS 271.85 -0.5% Stock price decreasing 2.8% Stock price increasing 0.2% Stock price increasing -1.6% Stock price decreasing 12.8% Stock price increasing 11.7% Stock price increasing
 
Bayer AG NA O.N. 66.59 3.1% Stock price increasing 12.5% Stock price increasing 23.5% Stock price increasing -0.5% Stock price decreasing -18.7% Stock price decreasing 10.0% Stock price increasing
 
Teva Pharmaceutical Industries.. 7.050 10.0% Stock price increasing -7.2% Stock price decreasing -35.1% Stock price decreasing -59.9% Stock price decreasing -69.4% Stock price decreasing -54.3% Stock price decreasing
 
Roche Holding AG Roche Holding.. 271.85 -0.5% Stock price decreasing 1.6% Stock price increasing 0.0% Stock price decreasing -1.8% Stock price decreasing 12.6% Stock price increasing 12.7% Stock price increasing

Company profile

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the company's sales are generated in the United States.

Peers

Instruments Last Change  
Abbott Labor.. 81.93 -2.9% Stock price decreasing
Baxter Inter.. 85.03 -2.5% Stock price decreasing
Bristol-Myer.. 46.58 -2.7% Stock price decreasing
Johnson & Jo.. 127.73 -2.7% Stock price decreasing
Eli Lilly an.. 109.51 -1.9% Stock price decreasing
Pfizer Inc 34.34 -2.1% Stock price decreasing
Gilead Scien.. 62.51 -2.7% Stock price decreasing
Astrazeneca .. 7,313.00 -0.2% Stock price decreasing
Merck Kgaa O.. 94.90 -0.3% Stock price decreasing
Glaxosmithkl.. 1,691.20 0.9% Stock price increasing
Sanofi 76.73 -0.4% Stock price decreasing
Novartis N 87.34 -0.5% Stock price decreasing
42,90,84,89,91,38,46,66,58,9
Roche GS 271.85 0.0% Stock price decreasing
16,80,77,90,97,43,42,71,78,7
Bayer AG NA .. 66.59 -1.7% Stock price decreasing
Teva Pharmac.. 7.050 -2.9% Stock price decreasing
Roche Holdin.. 271.85 0.0% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 August 2019 08:53:39
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB7 - 2019-08-25 09:53:39 - 2019-08-25 08:53:39 - 1000 - Website: OKAY